How bad is Cigna insurance?
DaVita Inc. is one of the largest kidney care and dialysis service providers in the United States, operating hundreds of outpatient centers that treat patients with chronic kidney failure. Public perceptions and evaluations of DaVita are mixed; while clinical quality metrics regarding dialysis treatments frequently meet or exceed national benchmarks set by health authorities, the organization has historically faced intense scrutiny, regulatory investigations, and federal whistleblower lawsuits concerning billing practices, corporate compliance, and physician kickback allegations. Patients often praise the compassionate frontline nursing staff, while critics monitor corporate legal settlements and operational cost pressures.
Related FAQs
Cipher Mining (trading under the ticker CIFR) has experienced capital structure adjustments typical of high-growth digital infrastructure and bitcoin mining enterprises, but it has not implemented a traditional retail-oriented stock split of its c...
Executive compensation for Stephen M. Spray, serving as the President and Chief Executive Officer of Cincinnati Financial Corporation, reflects leadership in the property and casualty insurance sector.
The Cigna Group (CI) is widely viewed favorably by Wall Street analysts, with a consensus rating that leans toward a "Strong Buy.
Cigna (CI) is generally considered to be undervalued by many market analysts and valuation models when compared to the company's long-term earnings potential.
No, Cigna is not as large as UnitedHealthcare. UnitedHealthcare is the largest health insurance provider in the United States, maintaining a significant advantage in terms of scale, diversification, and overall profitability.
Yes, The Cigna Group is performing well financially. The company reported strong results for the first quarter of 2026, with total revenues of $68.5 billion, representing a 5% increase compared to the previous year.
The outlook for Cigna's stock in 2026 is generally positive, with many Wall Street analysts forecasting growth. As of late July 2026, the average price target set by analysts for Cigna Group shares is approximately $338.
Yes, Cigna announced a significant workforce reduction in early 2026. The company laid off approximately 2,000 employees, which represents just under 3% of its global workforce of about 73,500 people.
As of late July 2026, the analyst consensus for The Cigna Group (CI) stock is a "Buy.